Halyard Health Inc. (NYSE:HYH)’s share price fell 1.5% on Monday . The stock traded as low as $33.83 and last traded at $33.93, with a volume of 210,349 shares trading hands. The stock had previously closed at $34.45.

Several research firms have recently weighed in on HYH. TheStreet raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. Stifel Nicolaus lifted their target price on shares of Halyard Health from $32.00 to $37.00 and gave the company a “buy” rating in a report on Tuesday, June 14th. Stephens began coverage on shares of Halyard Health in a report on Friday, April 8th. They set an “overweight” rating for the company. Zacks Investment Research raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Wednesday, March 30th. Finally, JMP Securities reaffirmed a “buy” rating on shares of Halyard Health in a report on Tuesday, April 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. Halyard Health currently has a consensus rating of “Buy” and an average price target of $33.80.

The company’s market cap is $1.58 billion. The stock’s 50 day moving average price is $32.87 and its 200-day moving average price is $29.11.

Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Wednesday, May 4th. The company reported $0.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.19. During the same period in the previous year, the company posted $0.51 earnings per share. The firm earned $385 million during the quarter, compared to analyst estimates of $369.80 million. Halyard Health’s revenue was down 2.3% compared to the same quarter last year. Equities analysts expect that Halyard Health Inc. will post $1.66 earnings per share for the current fiscal year.

Several large investors have recently bought and sold shares of HYH. Paradice Investment Management LLC increased its stake in Halyard Health by 59.0% in the fourth quarter. Paradice Investment Management LLC now owns 1,057,009 shares of the company’s stock valued at $35,315,000 after buying an additional 392,370 shares during the last quarter. New York State Common Retirement Fund increased its stake in Halyard Health by 168.1% in the fourth quarter. New York State Common Retirement Fund now owns 147,992 shares of the company’s stock valued at $4,944,000 after buying an additional 92,791 shares during the last quarter. California State Teachers Retirement System increased its stake in Halyard Health by 1.5% in the fourth quarter. California State Teachers Retirement System now owns 86,197 shares of the company’s stock valued at $2,880,000 after buying an additional 1,305 shares during the last quarter. Nationwide Fund Advisors increased its stake in Halyard Health by 0.5% in the fourth quarter. Nationwide Fund Advisors now owns 106,887 shares of the company’s stock valued at $3,571,000 after buying an additional 493 shares during the last quarter. Finally, California Public Employees Retirement System increased its stake in Halyard Health by 9.4% in the fourth quarter. California Public Employees Retirement System now owns 162,745 shares of the company’s stock valued at $5,437,000 after buying an additional 14,000 shares during the last quarter.

Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.